SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron

SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients

(2021) Yao Deng et al.   Cellular & Molecular Immunology

Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains

(2021) Maja Stanojevic et al.   CYTOTHERAPY

Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology

(2021) Sophie Steiner et al.   Frontiers in Immunology

SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees

(2021) Daryl Geers et al.   Science Immunology

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

(2021) Lihong Liu et al.   NATURE

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

(2021) Yunlong Cao et al.   NATURE

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

(2021) Delphine Planas et al.   NATURE

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data

(2020) Birkir Reynisson et al.   NUCLEIC ACIDS RESEARCH

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

(2020) Carolyn Rydyznski Moderbacher et al.   CELL

The Immune Epitope Database (IEDB): 2018 update

(2018) Randi Vita et al.   NUCLEIC ACIDS RESEARCH